Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects

Mol Nutr Food Res. 2009 Mar;53(3):370-6. doi: 10.1002/mnfr.200800132.

Abstract

We have earlier demonstrated that muesli enriched with oat beta-glucan effectively lowered serum LDL cholesterol. Addition of plant stanols further lowered LDL cholesterol. Besides these hypocholesterolemic effects, beta-glucan and plant stanol esters (PSE) may also affect inflammatory processes. Forty-two mildly hypercholesterolemic subjects randomly consumed for 4 wk (crossover design) control muesli (4.8 g control fiber), beta-glucan muesli (4.8 g oat beta-glucan), or combination muesli (4.8 g oat beta-glucan plus 1.4 g stanol as PSE). Changes in cytokine production (IL-6, IL-8, and TNF-alpha) of LPS-stimulated peripheral blood mononuclear cells (PBMC) and whole blood were evaluated, as well as changes in plasma high-sensitivity (hs)-CRP. Additionally, changes in expression profiles of 84 genes involved in atherosclerosis metabolism were assessed in isolated PBMC. IL-6, IL-8, and TNF-alpha production by PBMC and whole blood after LPS stimulation did not differ between the treatments. Also high-sensitivity C-reactive protein (hs-CRP) levels were similar. beta-Glucan consumption did not change gene expression, while only 3 genes (ADFP, CDH5, CSF2) out of the 84 genes from the atherosclerotic risk panel were differentially expressed (p < 0.05) after consumption of PSE. Consumption of beta-glucan with or without PSE did not influence inflammatory parameters in mildly hypercholesterolemic subjects.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atherosclerosis / genetics
  • Avena / chemistry*
  • C-Reactive Protein / analysis
  • Cross-Over Studies
  • Dietary Fiber / administration & dosage
  • Double-Blind Method
  • Female
  • Gene Expression / drug effects
  • Genetic Predisposition to Disease
  • Humans
  • Hypercholesterolemia / blood*
  • Inflammation / blood*
  • Interleukin-1 / blood
  • Interleukin-8 / blood
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Lipopolysaccharides / pharmacology
  • Male
  • Middle Aged
  • Sitosterols / administration & dosage*
  • Tumor Necrosis Factor-alpha / blood
  • beta-Glucans / administration & dosage*

Substances

  • Dietary Fiber
  • Interleukin-1
  • Interleukin-8
  • Lipopolysaccharides
  • Sitosterols
  • Tumor Necrosis Factor-alpha
  • beta-Glucans
  • plant stanol ester
  • C-Reactive Protein